Targeting p38α, p38γ, and ERα with bioactive compounds from royal jelly for anti-breast cancer activity: A comprehensive in-silico study using fingerprint analysis, molecular dynamics, MEP, and PCA
- DOI
- 10.1016/j.bbrc.2026.153555
- Published
- 2026-04
- Container
- Biochemical and Biophysical Research Communications
- Publisher
- Elsevier BV
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1016/j.bbrc.2026.153555,
title = {Targeting p38α, p38γ, and ERα with bioactive compounds from royal jelly for anti-breast cancer activity: A comprehensive in-silico study using fingerprint analysis, molecular dynamics, MEP, and PCA},
author = {Gusnia Meilin Gholam and Dimas Andrianto and Yelin Adalina and I Made Artika},
year = {2026},
journal = {Biochemical and Biophysical Research Communications},
doi = {10.1016/j.bbrc.2026.153555},
url = {https://doi.org/10.1016/j.bbrc.2026.153555}
}RIS
TY - JOUR TI - Targeting p38α, p38γ, and ERα with bioactive compounds from royal jelly for anti-breast cancer activity: A comprehensive in-silico study using fingerprint analysis, molecular dynamics, MEP, and PCA AU - Gusnia Meilin Gholam AU - Dimas Andrianto AU - Yelin Adalina AU - I Made Artika PY - 2026 JO - Biochemical and Biophysical Research Communications DO - 10.1016/j.bbrc.2026.153555 UR - https://doi.org/10.1016/j.bbrc.2026.153555 ER -
APA
Gholam, G. M., Andrianto, D., Adalina, Y., & Artika, I. M. (2026). Targeting p38α, p38γ, and ERα with bioactive compounds from royal jelly for anti-breast cancer activity: A comprehensive in-silico study using fingerprint analysis, molecular dynamics, MEP, and PCA. Biochemical and Biophysical Research Communications. https://doi.org/10.1016/j.bbrc.2026.153555
Source records
- crossref · retrieved 2026-09-26T01:40:58.389Z